Regulation of immune system by immune checkpoint blockade (ICB), such as anti-CTLA4, anti-PD1 and anti-PDL1, leads to durable responses in human pan-cancer (Hiam-Galvez et al. 2021). The gene discussed is PDCD1; the disease is cancer.